share_log

瀾滄古茶:董事名單及其角色與職能

LANCANG TEA: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

Hong Kong Stock Exchange ·  Jul 17 10:26
Summary by Moomoo AI
澜沧古茶(股份代號:6911)於2024年7月17日公布了其董事會成員及其在各董事委員會的角色與職能。董事會成員包括執行董事杜春嶧女士擔任董事長,王娟女士為總經理,以及張慕衡先生、石一景女士、付剛先生、劉佳杰先生擔任董事。非執行董事為周信忠先生,而獨立非執行董事包括曹瑋女士、謝曉堯博士、湯章亮先生和楊克泉博士。曹瑋女士在審計委員會、薪酬與考核委員會、提名委員會和戰略委員會均擔任主席,而謝曉堯博士則在薪酬與考核委員會和提名委員會擔任主席。此次公布的信息有助於投資者更好地了解公司的治理結構和董事會成員的分工。
澜沧古茶(股份代號:6911)於2024年7月17日公布了其董事會成員及其在各董事委員會的角色與職能。董事會成員包括執行董事杜春嶧女士擔任董事長,王娟女士為總經理,以及張慕衡先生、石一景女士、付剛先生、劉佳杰先生擔任董事。非執行董事為周信忠先生,而獨立非執行董事包括曹瑋女士、謝曉堯博士、湯章亮先生和楊克泉博士。曹瑋女士在審計委員會、薪酬與考核委員會、提名委員會和戰略委員會均擔任主席,而謝曉堯博士則在薪酬與考核委員會和提名委員會擔任主席。此次公布的信息有助於投資者更好地了解公司的治理結構和董事會成員的分工。
On July 17, 2024, Lanchang Ancient Tea (stock code: 6911) announced its board of directors and their roles and functions in each director committee. The members of the board of directors include Ms. Du Chunjie as executive director and chairman, Ms. Wang Juan as general manager, and Mr. Zhang Muheng, Ms. Shi Yijing, Mr. Fu Gang, and Mr. Liu Jiajie as directors. Mr. Zhou Xinzong is a non-executive director, while independent non-executive directors include Ms. Cao Wei, Dr. Xie Xiaoyao, Mr. Tang Zhangliang, and Dr. Yang Kequan. Ms. Cao Wei serves as chairman of the audit committee, the remuneration and assessment committee, the nomination committee, and the strategic committee, while Dr. Xie Xiaoyao serves as chairman of the remuneration and assessment committee and the nomination committee. This information helps investors better understand the company's governance structure and the division of labor among its board members.
On July 17, 2024, Lanchang Ancient Tea (stock code: 6911) announced its board of directors and their roles and functions in each director committee. The members of the board of directors include Ms. Du Chunjie as executive director and chairman, Ms. Wang Juan as general manager, and Mr. Zhang Muheng, Ms. Shi Yijing, Mr. Fu Gang, and Mr. Liu Jiajie as directors. Mr. Zhou Xinzong is a non-executive director, while independent non-executive directors include Ms. Cao Wei, Dr. Xie Xiaoyao, Mr. Tang Zhangliang, and Dr. Yang Kequan. Ms. Cao Wei serves as chairman of the audit committee, the remuneration and assessment committee, the nomination committee, and the strategic committee, while Dr. Xie Xiaoyao serves as chairman of the remuneration and assessment committee and the nomination committee. This information helps investors better understand the company's governance structure and the division of labor among its board members.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more